Suppr超能文献

肥胖症的药物治疗:最新进展

Pharmacotherapy of obesity: an update.

作者信息

Schurgin Sunita, Siegel Richard D

机构信息

Division of Endocrinology, Diabetes, Metabolism and Molecular Medicine, Tufts-New England Medical Center, Boston, MA 02111, USA.

出版信息

Nutr Clin Care. 2003 Jan-Apr;6(1):27-37.

Abstract

There has been an epidemic of obesity in the last decade. In spite of the rising numbers of people who are overweight and obese, medical treatment of obesity is currently where medical treatment of hypertension was in the 1950s with only two Food and Drug Administration-approved medications for chronic weight loss and maintenance, sibutramine and orlistat. This article reviews these medications and others currently being used for weight loss and weight maintenance. Available medications for obesity include drugs that affect caloric intake and appetite and alter energy expenditure and nutrient absorption, as well as some with an unclear mechanism of action at present. Dozens of drugs in different phases of clinical investigation could be available in the next decade.

摘要

在过去十年里,肥胖现象盛行。尽管超重和肥胖的人数不断增加,但目前肥胖症的医学治疗水平相当于20世纪50年代高血压的医学治疗水平,美国食品药品监督管理局仅批准了两种用于慢性减肥和维持体重的药物,即西布曲明和奥利司他。本文综述了这些药物以及目前用于减肥和维持体重的其他药物。现有的肥胖症治疗药物包括影响热量摄入和食欲、改变能量消耗和营养吸收的药物,以及一些目前作用机制尚不清楚的药物。未来十年可能会有几十种处于不同临床研究阶段的药物可供使用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验